Excerpt The term thalassaemia intermedia describes a form of thalassaemia of intermediate severity between the major, transfusion-dependent forms of the disease and the symptomless carrier states. The term includes many different varieties of thalassaemia including the compound heterozygous state for mild and severe beta thalassaemia mutations or forms of homozygous beta thalassaemia in which genetic modifiers have reduced the severity of the disease, diseases like haemoglobin E beta thalassaemia due to the co-inheritance of a structural haemoglobin variant with beta thalassaemia, the compound heterozygous states for other structural variants such as haemoglobins S or C and beta thalassaemia and a heterogeneous group of forms of alpha thalassaemia that produce haemoglobin H disease of varying severity. The wide clinical variability of these conditions leads to major difficulties in their management. These problems have been magnified over recent years by the discovery that in many forms of thalassaemia intermedia there are a wide range of complications which tend to occur later in the lives of affected patients. © 2013 Thalassaemia International Federation.

Guidelines for the management of nn transfusion dependent thalassaemia (NTDT) / A. Taher, E. Vichinsky, K. Musallam, M.D. Cappellini, V. Viprakasit - In: Guidelines fo the management of non transfusion dependent thalassaemia (NTDT) / [a cura di] D. Weatherall. - 2013. - Nycosia, Cyprus : TIF - Thalassaemia International Federation, 2013. - ISBN 978-9963-717-03-3.

Guidelines for the management of nn transfusion dependent thalassaemia (NTDT)

M.D. Cappellini
Penultimo
;
2013

Abstract

Excerpt The term thalassaemia intermedia describes a form of thalassaemia of intermediate severity between the major, transfusion-dependent forms of the disease and the symptomless carrier states. The term includes many different varieties of thalassaemia including the compound heterozygous state for mild and severe beta thalassaemia mutations or forms of homozygous beta thalassaemia in which genetic modifiers have reduced the severity of the disease, diseases like haemoglobin E beta thalassaemia due to the co-inheritance of a structural haemoglobin variant with beta thalassaemia, the compound heterozygous states for other structural variants such as haemoglobins S or C and beta thalassaemia and a heterogeneous group of forms of alpha thalassaemia that produce haemoglobin H disease of varying severity. The wide clinical variability of these conditions leads to major difficulties in their management. These problems have been magnified over recent years by the discovery that in many forms of thalassaemia intermedia there are a wide range of complications which tend to occur later in the lives of affected patients. © 2013 Thalassaemia International Federation.
Settore MED/09 - Medicina Interna
2013
Book Part (author)
File in questo prodotto:
File Dimensione Formato  
Guidelines Thalassaemia NTDT.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 5.76 MB
Formato Adobe PDF
5.76 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/254766
Citazioni
  • ???jsp.display-item.citation.pmc??? 95
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact